InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by O'Toole David D, Chief Financial Officer. Director active across 1 companies, notably Opiant Pharmaceuticals, INC.. Aggregated, 9 filings have been published. Total volume traded: €45k. The latest transaction was disclosed on 27 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations9 total
02,000 shares0
Common Stock
SEC:0001385508-22-000102:0·
€11,643432 shares@ €26.950952.0% of flow
Common Stock
SEC:0001385508-22-000022·
€11,643432 shares@ €26.950926.0% of flow
Common Stock
SEC:0001385508-22-000022:0·
012,000 shares0
Common Stock
SEC:0001385508-22-000012·
012,000 shares0
Common Stock
SEC:0001385508-22-000012:0·
€2,901179 shares@ €16.20513.0% of flow
Common Stock
SEC:0001385508-21-000132·
Ideal exit: 11 Jun 2022 (T+270)
€2,901179 shares@ €16.2056.5% of flow
Common Stock
SEC:0001385508-21-000132:0·
Ideal exit: 11 Jun 2022 (T+270)
€7,834600 shares@ €13.056135.0% of flow
Common Stock
SEC:0001385508-21-000111·
Ideal exit: 13 May 2022 (T+270)
€7,834600 shares@ €13.056117.5% of flow
Common Stock
SEC:0001385508-21-000111:0·
Ideal exit: 13 May 2022 (T+270)
9 of 9 declarations
About O'Toole David D
David D. O'Toole is the Chief Financial Officer of Opiant Pharmaceuticals, Inc., a company specializing in developing treatments for substance use disorders. In this role, he oversees the financial management of the company, including financial planning and analysis. With expertise in finance, he contributes to the company's financial strategy.
